Home › Research › Topics › intestinal
intestinal
273 studies tagged intestinal, dated 1995-01-01 to 2026-10-23. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Evidence that the perinatal maternal microbiome mediates metabolite signaling programs that drive sex-specific microglial metabolic alterations and Alzheimer’s disease susceptibility 2026-10-23
- Change in gut microbiome precedes symptomatic Alzheimer’s disease and is correlated with amyloid-beta accumulation in the brain 2026-10-19
- The Gut–Liver–Brain Axis in Neurodegeneration: Unraveling Metabolic–Immune Crosstalk from Peripheral Sensing to Central Vulnerability 2026-10-08
Studies
273 studies carry this tag.
Date range
1995 to 2026
Top journals
- Journal of Alzheimer's disease : JAD 13
- Scientific reports 8
- Nutrients 7
- Brain, behavior, and immunity 6
- Frontiers in cellular and infection microbiology 6
168 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Dementia is a comprehensive category of brain diseases that is great enough to affect a person's daily functioning.
-
Alzheimer's disease (AD) is associated with severe cognitive impairments as well as some metabolic defects.
-
36/100
It has been hypothesized that alterations in the composition of the gut microbiota might be associated with the onset of certain human pathologies, such as Alzheimer disease, a neurodegenerative syndrome associated with cerebral accumulation of amyloid-β fibrils.
-
The human microbiome consists of ~3.8 × 10 13 symbiotic microorganisms that form a highly complex and dynamic ecosystem: the gastrointestinal (GI) tract constitutes the largest repository of the human microbiome by far, and its impact on human neurological health and disease is becoming increasingly appreciated.
-
Amy+ patients showed higher levels of pro-inflammatory cytokines (IL-6, CXCL2, NLRP3, and IL-1β) compared with both controls and with Amy- patients.
-
The oral microbiome is established within a few minutes after birth and consists of stable multi-species communities that engage in a dynamic equilibrium with the host immune system.
-
Alzheimer's disease (AD) is a most common neurodegenerative disorder, which associates with impaired cognition.
-
Employing an integrated computational approach, we provide intriguing and supporting evidence for a role of microbial metabolites, an important modifiable environmental factor, in AD etiology.
-
Gastro-intestinal (GI) microbiota and the 'gut-brain axis' are proving to be increasingly relevant to early brain development and the emergence of psychiatric disorders.
-
Severe amyloidosis and plaque-localized neuro-inflammation are key pathological features of Alzheimer's disease (AD).
-
The enteric nervous system (ENS) is large, complex and uniquely able to orchestrate gastrointestinal behaviour independently of the central nervous system (CNS).
-
IBS is associated with an increased risk of dementia, and this effect is obvious only in patients who are ≥50 years old.
-
The hypothesis of an important role of gut microbiota in the maintenance of physiological state into the gastrointestinal (GI) system is supported by several studies that have shown a qualitative and quantitative alteration of the intestinal flora in a number of gastrointestinal and extra-gastrointestinal diseases.
-
The gut microbiome comprises the collective genome of the trillions of microorganisms residing in our gastrointestinal ecosystem.
-
Probiotics actively participate in neuropsychiatric disorders.
-
Scope Grape seed polyphenol extract (GSPE) is receiving increasing attention for its potential preventative and therapeutic roles in Alzheimer's disease (AD) and other age-related neurodegenerative disorders.
-
The concept of molecular mimicry was established to explain commonalities of structure which developed in response to evolutionary pressures.
-
This review, gathered from diverse sources, shows how our microbiome influences health and ultimately how well we age.
-
69/100
Serum IgG levels to common periodontal microbiota are associated with risk for developing incident AD.
-
Epidemiological studies have shown a clear association between maternal infection and schizophrenia or autism in the progeny.
-
Cytokine-induced sickness behavior was recognized within a few years of the cloning and expression of interferon-alpha, IL-1 and IL-2, which occurred around the time that the first issue of Brain, Behavior, and Immunity was published in 1987.
-
36/100
Inflammatory processes may play a critical role in the pathogenesis of the degenerative changes and cognitive impairments associated with Alzheimer's disease (AD).
-
In addition to a physiological role for CRF in integrating the responses of the brain, endocrine and immune systems to physiological, psychological and immunological stimuli, recent clinical data implicate CRF in the etiology and pathophysiology of various endocrine, psychiatric, neurologic and inflammatory illnesses.
From across this tag
10 of the 273 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders
- Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study
- Microbiota-gut-brain axis and the central nervous system
- Time to test antibacterial therapy in Alzheimer's disease
- Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
- Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease
- The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders
- Extra-virgin olive oil and the gut-brain axis: influence on gut microbiota, mucosal immunity, and cardiometabolic and cognitive health
- Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
- Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease